Protein accumulations do important work in the human body, but something can go wrong and proliferate in those aggregates, ...

Deep sleep could be key to forestalling slow declines in brain health that may one day lead to Alzheimer's disease, the most common form of dementia.

Topline data from the pivotal INFRONT-3 Phase 3 clinical trial of latozinemab in FTD-GRN expected by Q4 2025Anticipate completing enrollment in ...

With early diagnosis of Alzheimer's disease comes the possibility of treatment to not only help manage symptoms but also slow ...

A new biomarker test can detect early-stage tau protein clumping up to a decade before it appears on brain scans, improving ...

Rather than looking for amyloid-beta plaques like many other Alzheimer's tests, this one hunts for tiny clumps of tau protein ...

The study focuses on how immune cells react to amyloid-beta (Aβ) plaques, a hallmark of Alzheimer's ... at the University of ...

Alzheimer’s disease — which affects an estimated 7 million Americans — is notoriously difficult to detect, especially in its ...

They also say that their graphene grid method could be used to determine the structures of other small and unstable proteins -- including the amyloid-beta peptide that builds up in the brain in ...

New research has revitalized interest in the longstanding link between brain trauma and dementia by focusing on the vascular ...

Researchers develop early Alzheimers diagnostic method using tau protein analysis Advancements in Alzheimers detection reveal early risks through tau protein mutations ...